Cargando…
Mycobacterium tuberculosis infection, immune activation, and risk of HIV acquisition
BACKGROUND: Although immune activation is associated with HIV acquisition, the nature of inflammatory profiles that increase HIV risk, which may include responses to M. tuberculosis (Mtb) infection, are not well characterized. METHODS: We conducted a nested case-control study using cryopreserved sam...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9064099/ https://www.ncbi.nlm.nih.gov/pubmed/35503767 http://dx.doi.org/10.1371/journal.pone.0267729 |
_version_ | 1784699295468879872 |
---|---|
author | Bender Ignacio, Rachel A. Long, Jessica Saha, Aparajita Nguyen, Felicia K. Joudeh, Lara Valinetz, Ethan Mendelsohn, Simon C. Scriba, Thomas J. Hatherill, Mark Janes, Holly Churchyard, Gavin Buchbinder, Susan Duerr, Ann Shah, Javeed A. Hawn, Thomas R. |
author_facet | Bender Ignacio, Rachel A. Long, Jessica Saha, Aparajita Nguyen, Felicia K. Joudeh, Lara Valinetz, Ethan Mendelsohn, Simon C. Scriba, Thomas J. Hatherill, Mark Janes, Holly Churchyard, Gavin Buchbinder, Susan Duerr, Ann Shah, Javeed A. Hawn, Thomas R. |
author_sort | Bender Ignacio, Rachel A. |
collection | PubMed |
description | BACKGROUND: Although immune activation is associated with HIV acquisition, the nature of inflammatory profiles that increase HIV risk, which may include responses to M. tuberculosis (Mtb) infection, are not well characterized. METHODS: We conducted a nested case-control study using cryopreserved samples from persons who did and did not acquire HIV during the multinational Step clinical trial of the MRKAd5 HIV-1 vaccine. PBMCs from the last HIV-negative sample from incident HIV cases and controls were stimulated with Mtb-specific antigens (ESAT-6/CFP-10) and analyzed by flow cytometry with intracellular cytokine staining and scored with COMPASS. We measured inflammatory profiles with five Correlates of TB Risk (CoR) transcriptomic signatures. Our primary analysis examined the association of latent Mtb infection (LTBI; IFNγ+CD4+ T cell frequency) or RISK6 CoR signature with HIV acquisition. Conditional logistic regression analyses, adjusted for known predictors of HIV acquisition, were employed to assess whether TB-associated immune markers were associated with HIV acquisition. RESULTS: Among 465 participants, LTBI prevalence (21.5% controls vs 19.1% cases, p = 0.51) and the RISK6 signature were not higher in those who acquired HIV. In exploratory analyses, Mtb antigen-specific polyfunctional CD4+ T cell COMPASS scores (aOR 0.96, 95% CI 0.77, 1.20) were not higher in those who acquired HIV. Two CoR signatures, Sweeney3 (aOR 1.38 (1.07, 1.78) per SD change) and RESPONSE5 (0.78 (0.61, 0.98)), were associated with HIV acquisition. The transcriptomic pattern used to differentiate active vs latent TB (Sweeney3) was most strongly associated with acquiring HIV. CONCLUSIONS: LTBI, Mtb polyfunctional antigen-specific CD4+ T cell activation, and RISK6 were not identified as risks for HIV acquisition. In exploratory transcriptomic analyses, two CoR signatures were associated with HIV risk after adjustment for known behavioral and clinical risk factors. We identified host gene expression signatures associated with HIV acquisition, but the observed effects are likely not mediated through Mtb infection. |
format | Online Article Text |
id | pubmed-9064099 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-90640992022-05-04 Mycobacterium tuberculosis infection, immune activation, and risk of HIV acquisition Bender Ignacio, Rachel A. Long, Jessica Saha, Aparajita Nguyen, Felicia K. Joudeh, Lara Valinetz, Ethan Mendelsohn, Simon C. Scriba, Thomas J. Hatherill, Mark Janes, Holly Churchyard, Gavin Buchbinder, Susan Duerr, Ann Shah, Javeed A. Hawn, Thomas R. PLoS One Research Article BACKGROUND: Although immune activation is associated with HIV acquisition, the nature of inflammatory profiles that increase HIV risk, which may include responses to M. tuberculosis (Mtb) infection, are not well characterized. METHODS: We conducted a nested case-control study using cryopreserved samples from persons who did and did not acquire HIV during the multinational Step clinical trial of the MRKAd5 HIV-1 vaccine. PBMCs from the last HIV-negative sample from incident HIV cases and controls were stimulated with Mtb-specific antigens (ESAT-6/CFP-10) and analyzed by flow cytometry with intracellular cytokine staining and scored with COMPASS. We measured inflammatory profiles with five Correlates of TB Risk (CoR) transcriptomic signatures. Our primary analysis examined the association of latent Mtb infection (LTBI; IFNγ+CD4+ T cell frequency) or RISK6 CoR signature with HIV acquisition. Conditional logistic regression analyses, adjusted for known predictors of HIV acquisition, were employed to assess whether TB-associated immune markers were associated with HIV acquisition. RESULTS: Among 465 participants, LTBI prevalence (21.5% controls vs 19.1% cases, p = 0.51) and the RISK6 signature were not higher in those who acquired HIV. In exploratory analyses, Mtb antigen-specific polyfunctional CD4+ T cell COMPASS scores (aOR 0.96, 95% CI 0.77, 1.20) were not higher in those who acquired HIV. Two CoR signatures, Sweeney3 (aOR 1.38 (1.07, 1.78) per SD change) and RESPONSE5 (0.78 (0.61, 0.98)), were associated with HIV acquisition. The transcriptomic pattern used to differentiate active vs latent TB (Sweeney3) was most strongly associated with acquiring HIV. CONCLUSIONS: LTBI, Mtb polyfunctional antigen-specific CD4+ T cell activation, and RISK6 were not identified as risks for HIV acquisition. In exploratory transcriptomic analyses, two CoR signatures were associated with HIV risk after adjustment for known behavioral and clinical risk factors. We identified host gene expression signatures associated with HIV acquisition, but the observed effects are likely not mediated through Mtb infection. Public Library of Science 2022-05-03 /pmc/articles/PMC9064099/ /pubmed/35503767 http://dx.doi.org/10.1371/journal.pone.0267729 Text en © 2022 Bender Ignacio et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Bender Ignacio, Rachel A. Long, Jessica Saha, Aparajita Nguyen, Felicia K. Joudeh, Lara Valinetz, Ethan Mendelsohn, Simon C. Scriba, Thomas J. Hatherill, Mark Janes, Holly Churchyard, Gavin Buchbinder, Susan Duerr, Ann Shah, Javeed A. Hawn, Thomas R. Mycobacterium tuberculosis infection, immune activation, and risk of HIV acquisition |
title | Mycobacterium tuberculosis infection, immune activation, and risk of HIV acquisition |
title_full | Mycobacterium tuberculosis infection, immune activation, and risk of HIV acquisition |
title_fullStr | Mycobacterium tuberculosis infection, immune activation, and risk of HIV acquisition |
title_full_unstemmed | Mycobacterium tuberculosis infection, immune activation, and risk of HIV acquisition |
title_short | Mycobacterium tuberculosis infection, immune activation, and risk of HIV acquisition |
title_sort | mycobacterium tuberculosis infection, immune activation, and risk of hiv acquisition |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9064099/ https://www.ncbi.nlm.nih.gov/pubmed/35503767 http://dx.doi.org/10.1371/journal.pone.0267729 |
work_keys_str_mv | AT benderignaciorachela mycobacteriumtuberculosisinfectionimmuneactivationandriskofhivacquisition AT longjessica mycobacteriumtuberculosisinfectionimmuneactivationandriskofhivacquisition AT sahaaparajita mycobacteriumtuberculosisinfectionimmuneactivationandriskofhivacquisition AT nguyenfeliciak mycobacteriumtuberculosisinfectionimmuneactivationandriskofhivacquisition AT joudehlara mycobacteriumtuberculosisinfectionimmuneactivationandriskofhivacquisition AT valinetzethan mycobacteriumtuberculosisinfectionimmuneactivationandriskofhivacquisition AT mendelsohnsimonc mycobacteriumtuberculosisinfectionimmuneactivationandriskofhivacquisition AT scribathomasj mycobacteriumtuberculosisinfectionimmuneactivationandriskofhivacquisition AT hatherillmark mycobacteriumtuberculosisinfectionimmuneactivationandriskofhivacquisition AT janesholly mycobacteriumtuberculosisinfectionimmuneactivationandriskofhivacquisition AT churchyardgavin mycobacteriumtuberculosisinfectionimmuneactivationandriskofhivacquisition AT buchbindersusan mycobacteriumtuberculosisinfectionimmuneactivationandriskofhivacquisition AT duerrann mycobacteriumtuberculosisinfectionimmuneactivationandriskofhivacquisition AT shahjaveeda mycobacteriumtuberculosisinfectionimmuneactivationandriskofhivacquisition AT hawnthomasr mycobacteriumtuberculosisinfectionimmuneactivationandriskofhivacquisition |